Medicinal applications of fullerenes - Wikidata - wikimedia - TriplyDB

Medicinal applications of fullerenes

Medicinal applications of fullerenes

http://www.wikidata.org/entity/Q37059906

about

Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?Carbon Nanomaterials Interfacing with Neurons: An In vivo Perspective The applications of buckminsterfullerene C60 and derivatives in orthopaedic research C₆₀ exposure augments cardiac ischemia/reperfusion injury and coronary artery contraction in Sprague Dawley rats Nanomaterial interactions with and trafficking across the lung alveolar epithelial barrier: implications for health effects of air-pollution particles PVP formulated fullerene (C60) increases Rho-kinase dependent vascular tissue contractility in pregnant Sprague Dawley rats Drought Impact Is Alleviated in Sugar Beets (Beta vulgaris L.) by Foliar Application of Fullerenol Nanoparticles Rational engineering of physicochemical properties of nanomaterials for biomedical applications with nanotoxicological perspectives Fullerol nanoparticles suppress inflammatory response and adipogenesis of vertebral bone marrow stromal cells--a potential novel treatment for intervertebral disc degeneration.Polyhydroxylated fullerene attenuates oxidative stress-induced apoptosis via a fortifying Nrf2-regulated cellular antioxidant defence system.Lipid-assisted formation and dispersion of aqueous and bilayer-embedded nano-C60 Encapsulation of a radiolabeled cluster inside a fullerene cage, (177)Lu(x)Lu((3-x))N@C(80): an interleukin-13-conjugated radiolabeled metallofullerene platform.Polyhydroxy fullerenes (fullerols or fullerenols): beneficial effects on growth and lifespan in diverse biological models.The baffling human body and the boundless nanomaterial boon-a trap for cancer crab.Nanotechnology in cosmetics: Opportunities and challenges.Lipid nanotechnology Strategies for quantifying C(60) fullerenes in environmental and biological samples and implications for studies in environmental health and ecotoxicology.Interaction of human serum album and C₆₀ aggregates in solution.Leveraging electrokinetics for the active control of dendritic fullerene-1 release across a nanochannel membrane.A zeta potential value determines the aggregate's size of penta-substituted [60]fullerene derivatives in aqueous suspension whereas positive charge is required for toxicity against bacterial cells Carboxylic Acid Fullerene (C60) Derivatives Attenuated Neuroinflammatory Responses by Modulating Mitochondrial Dynamics.Nanotechnology: A Revolution in Cancer Diagnosis Effect of buckminsterfullerenes on cells of the innate and adaptive immune system: an in vitro study with human peripheral blood mononuclear cells.Influence of fullerene (C60) on soil bacterial communities: aqueous aggregate size and solvent co-introduction effects Evaluation of extraction methods for quantification of aqueous fullerenes in urine Designing a C84 fullerene as a specific voltage-gated sodium channel blocker Functionalized Fullerene Increases NF-κB Activity and Blocks Genotoxic Effect of Oxidative Stress in Serum-Starving Human Embryo Lung Diploid Fibroblasts Fullerene Derivatives Strongly Inhibit HIV-1 Replication by Affecting Virus Maturation without Impairing Protease Activity.Biomedical applications of functionalized fullerene-based nanomaterials.Neurodegenerative disorders and nanoformulated drug development.A new class of human mast cell and peripheral blood basophil stabilizers that differentially control allergic mediator release.Design and Biological Evaluation of Delivery Systems Containing Bisphosphonates Advances in polymeric and inorganic vectors for nonviral nucleic acid delivery.Fullerene nanomaterials inhibit phorbol myristate acetate-induced inflammation.Targeting Oxidative Stress in Central Nervous System Disorders Photodynamic activity of viral nanoparticles conjugated with C60.Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials Uptake and distribution of fullerenes in human mast cells.Dendrimer-Fullerenol Soft-Condensed Nanoassembly.

P2860

Q24599399-5FD4B53C-D420-4E56-9D99-22A26AB36A1F Q26745423-75234563-67C1-42DE-8E63-2E851B978AB8 Q27008643-BBF8614D-D8D2-4518-9174-E71D0B33D3DD Q28384681-E250EA24-AEEE-4F59-A871-539F2D9B007B Q28385393-059E54A2-66FF-410B-B778-3384032222D5 Q28387072-974A201D-5845-4C2A-A7EA-65779FB59079 Q28553476-5F79D634-FE24-4DF3-90AA-512CAA21490E Q28818039-C3E4327B-0C66-4EE7-BABB-6B1883A08C98 Q30409893-936D888D-8739-4F69-BE6E-B02D3F1D072C Q33568603-DFE6BE1E-F3E5-4E98-AC02-DA6B4CEF4954 Q33844844-5724AA13-1B59-4674-91A1-C32C546E89A7 Q33871781-FEB238C0-43F1-4D1B-AA19-4CC712EA9400 Q33921101-15C8CC11-51EA-4089-9110-1B2534BB1679 Q34108716-37655311-8FBF-4EFB-8566-6985114F828B Q34296083-FB97A002-E44A-4B2B-ACF9-E665F89D0281 Q34328972-D2DCE482-A074-462A-97DF-679632D8E8B8 Q34607220-FEFF0185-CF0A-48E5-BE2A-2AB4C6306E3C Q35229465-4953F08A-3D4B-44E5-A478-D2151372FC0E Q35566327-3E095BF5-CA1A-4C96-9172-D084A5466C0A Q35740168-7A69FF9A-3396-4E25-B050-573BBC272645 Q35783208-121069B2-8D3F-4190-9A9D-9C34F25DEF22 Q36080018-6C8E802A-D25A-4FA6-A1D3-AD04DBB00790 Q36191337-1ABE1387-4566-46ED-9204-D447C3BBB81F Q37010588-C0EC80A0-2F9F-4F60-AD32-D638BB2532F1 Q37012158-040E2A45-9761-496E-9357-6804E746E8DA Q37053623-C5719ADB-2AA0-436F-B70E-01425F664E5C Q37231775-72CDE72C-E4BA-428E-94FF-1D40DE8F93AA Q37287731-B3C230FE-EF4D-4DCF-8ED7-12BE8D0BBD8B Q37461946-EB0B61A2-2E3E-4846-9D26-F246C78DDF5F Q37538771-546D521B-E0E6-4765-B1D1-7C3EDAEA0B08 Q37700388-EDAD27D6-476D-4AAC-A623-131D3406D242 Q37731222-B73408DE-082E-470E-8D4A-8CA8D3AB18D3 Q38028961-6283A24D-F7CA-46FB-9AB4-781B6B7A9FB6 Q38282506-5A3A4F08-DCB2-4711-B323-3923E59EF184 Q38918789-E175DE85-F65B-4BCF-ADD1-FB150A5B6E90 Q39303277-2871E468-6C48-4744-A720-0BAE359DA730 Q39400621-53885B83-65D7-4616-98E2-C212B0644243 Q40842291-F47AFF6A-2F1E-4FB5-BA78-2636A46000E5 Q41209214-9B7AFFBF-ED55-49FF-9BF6-15BBF79A1D96 Q41828400-C7F05FD7-FEDB-4F2D-B361-00859C814A24

P2860

Medicinal applications of fullerenes

http://www.wikidata.org/entity/Q37059906

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Medicinal applications of fullerenes

@en

Medicinal applications of fullerenes.

@nl

type

label

Medicinal applications of fullerenes

@en

Medicinal applications of fullerenes.

@nl

prefLabel

Medicinal applications of fullerenes

@en

Medicinal applications of fullerenes.

@nl

P1433

Q37059906-215F4ABB-D630-4BAA-9EED-F397B3772650

P1476

Q37059906-32863B7E-89D8-4AB9-98A4-39C59A68AA8B

P2093

Q37059906-3189B0D1-74A9-4AB7-BED3-BE3B4896BEC8

Q37059906-34C5F16E-3D4E-4EB8-9E92-655B5ACCE4E2

Q37059906-3B8EA227-8EBA-4A24-8020-4F15D5DD62D9

Q37059906-3D8F832E-3A0D-4DDE-AE34-94DA268A72AE

Q37059906-43FA6840-7F92-47BA-B393-C3B42D5A9E2E

Q37059906-6EDF6C5E-B52D-475D-B1FB-895AC3A7E0FA

Q37059906-DCC47F01-1A79-45DD-9369-196868998F29

P2860

Q37059906-05177BA5-F9F6-4745-90FA-CA9A92D8D064

Q37059906-0C18D289-4186-41A9-A486-EEF3C367662B

Q37059906-14A79B42-634C-41A9-B850-8DE1739C02B2

Q37059906-16F5605C-DC26-48A2-A075-3A583390525B

Q37059906-19BB0898-42DC-46DE-B7AB-DE2B5EFD7389

Q37059906-21FA2215-E5D0-4715-947E-0B2682730E79

Q37059906-2725C41D-4669-49D4-80FE-490899B0B116

Q37059906-2EA33032-10B4-4205-ADB7-873483827A9D

Q37059906-36A48B02-1765-4A47-81BE-6734906588EF

Q37059906-3A9F4302-4C5D-43CD-86F8-E7B1413A3908

P304

Q37059906-7D4F3317-5830-4915-8FCA-8FC797F24832

P31

Q37059906-A5D55EA1-9A02-4751-BFD7-B4F7DEB042CB

Q37059906-AF46A456-2E01-4025-86C2-948925E40BB3

P407

Q37059906-0A4026AF-26E9-4EC3-9E1A-7054FD56E95A

P433

Q37059906-0E7018FC-264F-4BFE-A185-F625AEBE8302

P478

Q37059906-E9B499FF-D410-4FA6-B75A-9783BCD95C42

P577

Q37059906-8778CDE2-281F-456A-87C6-AEBD0BDC1688

P698

Q37059906-C9A7E692-BD28-435E-9765-6D3B64C13E09

P921

Q37059906-2B4E73D2-CEA1-4689-8E0A-5A85C428B9E9

Q37059906-4FE3C036-8B0C-4DD0-8BF9-C77CD099F36A

Q37059906-5ABCBBA0-57C6-4772-B2A2-7A88D2256617

Q37059906-95B57A68-954A-4ACF-B665-8FDE1C6967A0

Q37059906-A497C667-0E75-4BD5-8B63-5497EA3EB3FC

Q37059906-AE79F295-E7C5-4972-A6F0-71EF1E5B5924

P932

Q37059906-A68ABA69-F120-4EE3-ABF0-2EE8C92EEC63

P1433

International Journal of Nanomedicine

P1476

Medicinal applications of fullerenes

@en

P2093

Christian W Huck

http://www.w3.org/2001/XMLSchema#string

Günther K Bonn

http://www.w3.org/2001/XMLSchema#string

Matthias Rainer

http://www.w3.org/2001/XMLSchema#string

Muhammad Najam-ul-Haq

http://www.w3.org/2001/XMLSchema#string

Rainer M Vallant

http://www.w3.org/2001/XMLSchema#string

Rania Bakry

http://www.w3.org/2001/XMLSchema#string

Zoltan Szabo

http://www.w3.org/2001/XMLSchema#string

P2860

Penetration of intact skin by quantum dots with diverse physicochemical properties

Design and synthesis of novel [60]fullerene derivatives as potential HIV aspartic protease inhibitors.

Cellular localisation of a water-soluble fullerene derivative.

C60 carboxyfullerene exerts a protective activity against oxidative stress-induced apoptosis in human peripheral blood mononuclear cells.

Material-enhanced laser desorption/ionization (MELDI)--a new protein profiling tool utilizing specific carrier materials for time of flight mass spectrometric analysis.

Ultra-fast mass fingerprinting by high-affinity capture of peptides and proteins on derivatized poly(glycidyl methacrylate/divinylbenzene) for the analysis of serum and cell lysates.

A new analytical material-enhanced laser desorption ionization (MELDI) based approach for the determination of low-mass serum constituents using fullerene derivatives for selective enrichment.

Carboxyfullerenes as neuroprotective agents.

[60]fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity.

Preclinical studies on safety of fullerene upon acute oral administration and evaluation for no mutagenesis.

P304

639-649

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18203430

http://www.w3.org/2001/XMLSchema#string

P921

inorganic compound

mechanism of action

manufactured product

pharmaceutical preparation

biomedical investigative technique

P932

2676811

http://www.w3.org/2001/XMLSchema#string